Stock data
Palisade Bio, Inc. (PALI)
Palisade Bio, Inc. (PALI) reported net income of -US$16.78M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$18.06M | -US$16.78M | — |
| 2024 | US$0.00M | — | -US$14.86M | -US$14.44M | — |
| 2023 | US$0.25M | — | -US$13.07M | -US$12.30M | — |
| 2022 | US$0.00M | — | -US$15.72M | -US$14.26M | — |
| 2021 | — | — | -US$41.85M | -US$26.62M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.50M | -US$10.57M | — |
| 2026-03-31 | — | -US$9.60M | — |
| 2025-12-31 | — | -US$8.90M | — |
| 2025-09-30 | — | -US$2.87M | — |
| 2025-06-30 | US$0.00M | -US$2.78M | — |
| 2025-03-31 | — | -US$2.23M | — |
| 2024-12-31 | US$0.00M | -US$3.34M | — |
| 2024-09-30 | US$0.00M | -US$3.49M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.